통합검색

한빛사

내가 찾은 검색어

1Renal clearance

'Renal clearance' 에 대한 통합검색결과 32건입니다.

한빛사32건

최신순
관련도순

Co-Delivery of Renal Clearable Cerium Complex and Synergistic Antioxidant Iron Complex for Treating Sepsis
- ACS Nano Oct 17 2024, | https://doi.org/10.1021/acsnano.4c05902
- 2024.10
- 바이오·의료융합
Optimization of micelle-encapsulated extremely small sized iron oxide nanoparticles as a T1 contrast imaging agent: biodistribution and safety profile
- J. Nanobiotechnol. Jul 16 2024, 22 (1) | https://doi.org/10.1186/s12951-024-02699-8
- 2024.07
- 바이오·의료융합
- 박혜상(Massachusetts General Hospital and Harvard Medical School, 한림대학교 의과대학)
- 최학수(Massachusetts General Hospital and Harvard Medical School)
Bifunctional Tumor-Targeted Bioprobe for Phothotheranosis
- Biomater. Res. 2024 Jan 25:28:0002 | https://doi.org/10.34133/bmr.0002
- 2024.01
- 바이오·의료융합
최세환

연세대학교, 현 원자력의학원

세포 내 신호 전달에 관여하는 단백질-단백질 상호 작용(Protein-protein Interaction, PPI)은 유망한 약물 타겟으로 간주되고 있지만, 구조적 특성상 넓고 얕은 결합 면으로 이뤄지기 때문에 현재로서는 기존의 소분자(Small Molecule)를 이용한 약물 개발이 쉽지 않은 실정입니다. 이에 다양한 기능성 잔기들을 가지고 있으며, 안정적인 이차 구조를 형성할 수 있고, PPI 인터페이스에 알맞은 크기를 가지고 있는 펩타이드는 효과적인 PPI 억제제로 작용할 수 있습니다.
- J. Control. Release
- 2024.01.12
Micro-syringe chip-guided intratumoral administration of lipid nanoparticles for targeted anticancer therapy
- Biomater. Res. Oct 16 2023, 27 (1) | https://doi.org/10.1186/s40824-023-00440-4
- 2023.10
- 바이오·의료융합
Recommendation of Pharmacokinetics/Pharmacodynamics Target of Ethambutol to Suppress Tuberculosis Resistance: A Population Pharmacokinetics Study on L
- Int. J. Antimicrob. Agents 7 May 2023, 106840 | https://doi.org/10.1016/j.ijantimicag.2023.106840
- 2023.05
- 의약학
Fasudil alleviates the vascular endothelial dysfunction and several phenotypes of Fabry disease
- Mol. Ther. 2023 Feb 8;S1525-0016(23)00066-7 | https://doi.org/10.1016/j.ymthe.2023.02.003
- 2023.02
- 생명과학
- 김현구(고려대학교)
- 최학수(Massachusetts General Hospital and Harvard Medical School)
Ultralow Background Near-Infrared Fluorophores with Dual-Channel Intraoperative Imaging Capability
- Adv. Healthc. Mater. 2023 Jan 14;e2203134 | https://doi.org/10.1002/adhm.202203134
- 2023.01
- 바이오·의료융합
- Thiruganesh Ramasamy(American Type Culture Collection, 영남대학교)
- 김종오(영남대학교)
Nano drug delivery systems for antisense oligonucleotides (ASO) therapeutics
- J. Control. Release 2022 Dec;352:861-878 | https://doi.org/10.1016/j.jconrel.2022.10.050
- 2022.12
- 바이오·의료융합
- 강호만(Massachusetts General Hospital and Harvard Medical School)
- 최학수(Massachusetts General Hospital and Harvard Medical School)
Image-guided drug delivery of nanotheranostics for targeted lung cancer therapy
- Theranostics 2022 May 13;12(9):4147-4162. | doi: 10.7150/thno.72803
- 2022.05
- 바이오·의료융합
- 최학수(Harvard Medical School)
Renal clearable zwitterionic near?infrared fluorophores for potential clinical translation
- Angew. Chem.-Int. Edit. First published: 15 April 2021 | https://doi.org/10.1002/anie.202102640
- 2021.04
- 바이오·의료융합
High-resolution T1 MRI via renally clearable dextran nanoparticles with an iron oxide shell
- Nat. Biomed. Eng. Published 8 March 2021 | https://doi.org/10.1038/s41551-021-00687-z
- 2021.03
- 바이오·의료융합
Kidney-Targeted Cytosolic Delivery of siRNA Using a Small-Sized Mirror DNA Tetrahedron for Enhanced Potency
- ACS Central Sci. Published online17 November 2020 | https://doi.org/10.1021/acscentsci.0c00763
- 2020.11
- 이석우(Massachusetts General Hospital)
Circulating testican-2 is a podocyte-derived marker of kidney health
- Proc. Natl. Acad. Sci. USA First published September 21, 2020 | https://doi.org/10.1073/pnas.2009606117
- 2020.09
Size-Dependent EPR Effect of Polymeric Nanoparticles on Tumor Targeting
- Adv. Healthc. Mater. Volume9, Issue1 January 8, 2020 1901223 | https://doi.org/10.1002/adhm.201901223
- 2020.01
- 바이오·의료융합
- 강호만(Massachusetts General Hospital, Harvard Medical School)
- 최학수(Massachusetts General Hospital , Harvard Medical School)
Renal Clearable Theranostic Nanoplatforms for Gastrointestinal Stromal Tumors
- Adv. Mater. First published: 18 December 2019 | https://doi.org/10.1002/adma.201905899
- 2019.12
- 바이오·의료융합
- 신동성(가천대학교 길병원)
- 유경상(서울대학교 의과대학)
Pharmacokinetics and tolerability of DA-8031, a novel selective serotonin reuptake inhibitor for premature ejaculation in healthy male subjects
- Drug Des. Dev. Ther. Published 10 March 2017, Volume 2017:11 Pages 713-723 | DOI https://doi.org/10.2147/DDDT.S126861
- 2017.03
- 강호만(Massachusetts General Hospital and Harvard Medical School)
  Interview
- 최학수(Massachusetts General Hospital and Harvard Medical School)
Renal Clearable Organic Nanocarriers for Bioimaging and Drug Delivery
- Adv. Mater. Version of Record online: 14 JUL 2016 | DOI: 10.1002/adma.201601101
- 2016.07
- 바이오·의료융합
Biodegradable Photonic Melanoidin for Theranostic Applications
- ACS Nano Publication Date (Web): December 1, 2015| DOI: 10.1021/acsnano.5b05931
- 2015.12
- 바이오·의료융합
TMBIM6 (transmembrane BAX inhibitor motif containing 6) Enhances Autophagy and Reduces Renal Dysfunction in a Cyclosporine A-induced nephrotoxicity mo
- Autophagy Accepted author version posted online: 25 Aug 2015 | DOI:10.1080/15548627.2015.1082021
- 2015.08
- 의약학